Colgate-Palmolive reported $21.0B of revenue over the trailing twelve months, +5.2% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $21.0B (to Q2 2026). Net income: $2.04B, trailing twelve months to Q2 2026. Free cash flow: $3.86B, trailing twelve months to Q2 2026. Operating margin: 15%, trailing twelve months to Q2 2026.

CLColgate-Palmolive

Consumer Defensive

$88.27+10% 1Y

$88.27

$74.0652 weeks$98.53

CL as reported

Colgate-Palmolive reported $21.0B of revenue over the trailing twelve months, +5.2% on the year before. 11 reported series are charted on this page, each one as filed.

$21.0B

Revenue, trailing twelve months · to Q2 2026 · +5.2% against the twelve months before

Net income: $2.04B
Net income · −30% year on year · trailing twelve months to Q2 2026
Free cash flow: $3.86B
Free cash flow · +14% year on year · trailing twelve months to Q2 2026
Operating margin: 15%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CL, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$21.0B	+5.2%	Q2 2026
Net income	$2.04B	−30%	Q2 2026
EPS	$2.53	−29%	Q2 2026
Gross margin	60%	n/a	Q2 2026
Operating margin	15%	n/a	Q2 2026
Net margin	9.7%	n/a	Q2 2026
ROE	1647%	n/a	Q2 2026
ROA	14%	n/a	Q2 2026
ROIC	41%	n/a	Q2 2026
Free cash flow	$3.86B	+14%	Q2 2026
P/E	34.9	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.